Switzerland approves Pfizer-BioNTech Covid-19 vaccine for emergency use, marking global first
Switzerland has become the first country to grant full approval for the Pfizer-BioNTech BNT162b2 Covid-19 vaccine, making a significant move in the global race against ... Read More
Appili Therapeutics begins Phase 3 clinical trial for Avigan in fight against Covid-19
Appili Therapeutics, a Canadian infectious disease biopharmaceutical company, has announced a major milestone in its fight against Covid-19: the commencement of the Phase 3 clinical ... Read More
UK grants emergency authorization for Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted emergency use authorization (EUA) for the BNT162b2 Covid-19 vaccine candidate, developed by Pfizer and ... Read More
Lilly signs $375m deal to supply Covid-19 candidate bamlanivimab to US govt
Eli Lilly and Company (Lilly) has signed a $375 million deal with the US government for the supply of 300,000 vials of bamlanivimab (LY-CoV555) 700mg, ... Read More
AstraZeneca resumes AZD1222 Covid-19 vaccine trials after brief pause
AstraZeneca said that clinical trials for the AZD1222 Covid-19 vaccine candidate, have resumed in various parts of the world after regulators across the US, UK, ... Read More
Covid-19 mRNA vaccine : Precision Nanosystems gets funding boost from Canadian govt
Precision Nanosystems (PNI) has received a funding boost of up to CAD 18.2 million from the Canadian government to develop a mRNA vaccine for Covid-19. ... Read More
Gilead Sciences bags Remdesivir FDA approval for Covid-19 treatment
Remdesivir FDA approval : Gilead Sciences, a California-based biopharma company, has bagged approval from the US Food and Drug Administration (FDA) for its antiviral drug ... Read More
Oxford develops rapid diagnostic test to detect Covid-19 within 5mins
Oxford University claimed that scientists from its Physics department have developed an extremely rapid diagnostic test for Covid-19. The rapid diagnostic test can detect and ... Read More
Novavax begins phase 3 trial of NVX-CoV2373 COVID-19 vaccine candidate
Novavax has initiated its first phase 3 clinical trial to assess the efficacy, safety, and immunogenicity of its NVX-CoV2373 COVID-19 vaccine candidate. The US vaccine ... Read More
J&J begins phase 3 ENSEMBLE Covid-19 vaccine trial for JNJ-78436735
ENSEMBLE Covid-19 vaccine trial : Johnson & Johnson (J&J) has launched a multi-nation phase 3 trial called ENSEMBLE for its JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S), ... Read More